VEOPOZ
RegisteredWord Mark
•
Ownership
RP
Owner Name
Type: Organization / Corporation
Address
777 Old Saw Mill River Road
Tarrytown, NY 10591
Critical Dates
First Use Date
Oct 19, 2023
Filing Date
Mar 8, 2022
Registration Date
Jan 9, 2024
Mark Descriptions
Goods
Class 5
Pharmaceutical preparations for the treatment of immunological, autoimmune, and genetic diseases and disorders
Mark Elements
Text Mark
VEOPOZ
Category
Trademark
Standard Characters
Yes
Color Claim
No
Data source: USPTO TSDR
View on USPTO websiteTrademark Timeline
First Use
Filing Date
Publication Date
Registration Date
USPTO Records
| Title | Date | Category | Source | Pages | Format | Actions |
|---|---|---|---|---|---|---|
AI AssessmentCached Mar 12, 2026, 08:55 AMCached
AI-generated analysis of USPTO data for this trademark. WARNING: Content may not be accurate or up to date. Validate all responses.
Trademark Summary
VEOPOZ is a standard character word mark owned by Regeneron Pharmaceuticals, Inc., a New York corporation, covering pharmaceutical preparations for the treatment of immunological, autoimmune, and genetic diseases and disorders in International Class 005, with additional domestic classes 006, 018, 044, 046, 051, and 052. The mark is registered on the Principal Register as of January 9, 2024, with registration number 7271822. It originated as a divisional child application from serial number 97301520, and class 005 is active.
Recent Activity
Filed on March 8, 2022, the application was published for opposition on January 24, 2023, followed by a Notice of Allowance on March 21, 2023. A statement of use was filed October 30, 2023, leading to registration on January 9, 2024; recent changes include attorney revocation/appointment and owner address updates on June 30, 2025.
USPTO
AI Analysis
v2.8.0
Never miss important updates for this trademark
Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach